Healio
Healio

Sitemap

November 17, 2020 Articles

Filter by Available Specialty

Filter by specialty

  1. ‘Another agent in our arsenal’: Finerenone benefits extend to those with, without CVD
  2. ‘Urgent investment required’ to get TB efforts back on track, group says
  3. ACR, medical societies lobby for legislation ensuring 'overdue' E/M rate increases
  4. AI program uses vocal biomarkers to diagnose COVID-19
  5. AMX0035 receives orphan drug designation for Wolfram syndrome
  6. Aspirin reduces risk for HCC in chronic hepatitis B
  7. Avacincaptad pegol reduces geographic atrophy growth rate at 18 months
  8. Balance needed between glaucoma treatment, management of ocular surface disease
  9. Baxter recalls leaking peritoneal dialysis transfer sets
  10. Belimumab plus standard therapy boosts renal outcomes, reduces steroids in lupus nephritis
  11. BLOG: The IOL sorting hat
  12. Boston Scientific recalls all Lotus Edge TAVR systems, halts research, manufacturing
  13. Calabrese offers path for the art and science of empathy in rheumatology
  14. Can glaucoma therapies be balanced with ocular surface health?
  15. Ceramic-on-polyethylene showed higher revision rate vs metal-on-polyethylene THA implants
  16. Choroidal thickness decreases after five anti-VEGF injections
  17. Combination therapies impact NAFLD more than singular therapy
  18. COVID, MIS-C show evidence of liver injury, require long-term monitoring
  19. COVID-19 CVD registry highlights racial/ethnic disparities, risk in obesity
  20. COVID-19-related job insecurity linked to young adult mental health burden
  21. Dexamethasone associated with lower risk for neonatal death, stillbirth
  22. Dextenza shows rapid, effective reduction of postoperative inflammation, pain
  23. Dislocated IOL needs to be repositioned for best performance
  24. Dry eye and the glaucoma patient
  25. Etanercept monotherapy superior to methotrexate in RA remission maintenance
  26. Fauci: Underlying CVD drives risk for COVID-19 severity, death
  27. FDA designates long-acting PrEP a breakthrough therapy
  28. FDA further delays decision on lisocabtagene maraleucel CAR-T for large B-cell lymphoma
  29. FDA grants priority review to APL-2 for paroxysmal nocturnal hemoglobinuria
  30. Glycemic control for pediatric type 1 diabetes improved during Italy’s COVID-19 lockdown
  31. Higher prevalence of hypothyroidism found in patients with Erdheim-Chester disease
  32. INVESTED: High-dose influenza vaccine fails to reduce death, CV events in high-risk cohort
  33. Laparoscopy comparable to open surgery for colorectal liver metastases
  34. Minimal monitoring program achieves SVR in hepatitis C
  35. Motivating factors for prescription stimulant misuse vary by age, education level
  36. Multiple subtypes of pediatric melanoma may be fatal
  37. Opioid use declines among elderly, but still ‘substantial’
  38. Options available, on the way to treat dry eye secondary to glaucoma
  39. Permanent night-shift work may elevate risk for moderate to severe asthma
  40. Positive outcomes seen with combined OPT-302, aflibercept for DME in phase 2a trial
  41. Prior intraocular inflammation cited as risk factor for adverse reaction to brolucizumab
  42. Progress in targeted myeloma therapies ‘amazing’
  43. Q&A: Tinnitus worsening amid pandemic in patients with, without COVID-19
  44. SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes
  45. Surgeons weigh value of same-day bilateral cataract surgery
  46. Thoracic visceral adipose tissue linked to pulmonary hypertension in transplant candidates
  47. Ticagrelor-aspirin treatment effect in THALES strongest in ipsilateral stenosis
  48. Top in ID: Surge in measles, monoclonal antibody for COVID-19
  49. US data report: Higher mortality rate seen for patients with vs without CKD
  50. VIDEO: Odevixibat well tolerated in progressive familial intrahepatic cholestasis
  51. Vitamin E-diffused polyethylene liners have a high resistance to linear wear after THA
  52. Woman presents with unilateral blurry vision